60 Degrees Pharmaceuticals, Inc. insider trading
Every open-market purchase and sale by 60 Degrees Pharmaceuticals, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $30,085 4 trades by 1 insider
3 months later: median −24.1% (−21.9% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following 60 Degrees Pharmaceuticals, Inc.’s insiders pay?
From February 2, 2024 to June 15, 2026, 2 insiders reported 6 open-market purchases and 0 sales not made under a pre-set plan in 60 Degrees Pharmaceuticals, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Dow Geoffrey S | President and CEO | 3 | — | — | 0 | — | June 15, 2026 |
| Xu Cheryl | Director | 3 | — | — | 0 | — | June 5, 2025 |
← Back to 60 Degrees Pharmaceuticals, Inc. · Funds · Politicians